アナフィラキシー治療市場は、2021 年の 26 億 6,466 万米ドルから 2028 年には 47 億 8,766 万米ドルに達すると予想されています。 2021 年から 2028 年にかけて 8.7% の CAGR で成長すると推定されています。
アナフィラキシーは、アナフィラキシーショックとして知られる致命的な状態をさらに引き起こす可能性があるアレルギー反応です。アナフィラキシーは、患者の体が異物に反応し、炎症反応を引き起こす大量のヒスタミンを生成するときに発生します。アメリカ喘息・アレルギー財団(AAFA)によると、米国では毎年約20万人が食物アレルギーのために病院を訪れています。アナフィラキシー治療市場の成長は、アナフィラキシー発生率の上昇や最近のエピネフリンの承認などの要因によるものと考えられます。ただし、低所得国ではエピネフリン自動注射器へのアクセスが悪いため、市場の成長が妨げられています。
アナフィラキシー治療市場で収益性の高い地域
< h3>市場に関する洞察
アナフィラキシーの発生率の増加
アナフィラキシーは、アレルゲン(食物、虫刺され、薬)に対する脆弱性によって引き起こされる、重篤で生命を脅かすアレルギー反応です。 )人体によって非自己として認識されます。この状態の典型的な症状としては、嚥下困難や呼吸困難、皮膚の発赤やかゆみ、心拍数の上昇、喘鳴、呼吸数の増加、血圧低下などが挙げられます。アナフィラキシーの発生率は世界中で増加しています。 National Institute for Health and Care Excellence (NICE) によると、英国ではアナフィラキシーにより毎年 20 人以上が死亡しています。欧州アレルギー・臨床免疫学会のデータによると、毎年約 1 億 5,000 万人のヨーロッパ人が慢性アレルギー疾患に苦しんでいます。したがって、アレルギーの発生率の上昇により、アナフィラキシーの症例が急増しています。さらに、American College of Allergy による Allergy Facts によると、喘息とアレルギーは次のとおりです。免疫学では、毎年 5,000 万人以上の人がさまざまな種類のアレルギーを経験しています。
1–米国人口の 15% は、1 つ以上のアレルゲンにさらされた場合にアナフィラキシー反応を起こすリスクがあり、これらの患者のうち最大 1% が死亡しますアナフィラキシーのせいで。この病気により、米国では年間約 1,500 人が死亡しています。また、アレルギーを慢性疾患の第 6 位の状況として挙げています。さらに、アメリカ喘息・アレルギー財団(AAFA)によれば、食物アレルギー反応の増加により、病院を受診する回数が増加しています。食物アレルギーは、年間 20 万件以上の緊急治療室 (ER) 来院の原因となっています。食物アレルギーの研究と研究教育によれば、3,200万人以上のアメリカ人が命を脅かす食物アレルギーを抱えて暮らしています。アレルギーの有病率の増加により、多くの国で医療システムに対する経済的負担が増大しています。たとえば、Allergy Facts によると、米国ではアレルギーの症例を管理するための年間コストが 180 億米ドルを超えています。したがって、アナフィラキシーの発生率の急増が市場の成長を推進しています。
薬剤の種類に基づく洞察
薬剤の種類に基づいて、アナフィラキシー治療市場は、エピネフリン、抗ヒスタミン薬、ステロイド、ベータ作動薬などに分類されます。エピネフリンセグメントは、2020 年に市場で最大のシェアを占め、予測期間中に市場で最高の CAGR を記録すると予想されています。
薬物別アナフィラキシー治療市場タイプ– 2020 年と 2028 年
投与経路に基づく洞察
投与経路に基づいて、アナフィラキシー治療市場は経口、非経口、その他に分類されます。 2020年には非経口セグメントが市場で最大のシェアを占めたが、経口セグメントは予測期間中に市場で最高のCAGR 8.9%を記録すると予想されている。
アレルギーの種類に基づく洞察
アナフィラキシー治療市場は、アレルギーの種類に基づいて、食物アレルギー、薬剤、虫刺されなどに分類されます。 。食物アレルギーセグメントは、2020 年の市場で最大のシェアを占め、予測期間中に市場で最高の CAGR を記録すると推定されています。
流通チャネルベースの分析情報
流通チャネルに基づいて、アナフィラキシー治療市場は病院の薬局、小売販売、ドラッグストアの郵送などに分類されます。小売販売セグメントは 2020 年に市場で最大のシェアを占め、予測期間中に市場で最高の CAGR を記録すると推定されています。
戦略的洞察
製品の発売と承認は、世界的な拠点と製品ポートフォリオを拡大するために企業が一般的に採用する戦略です。さらに、アナフィラキシー治療市場のプレーヤーは、顧客層を拡大するためのコラボレーション戦略に焦点を当てており、これにより、世界的にブランド名を維持することが可能になります。
アナフィラキシー治療市場–薬の種類別
- エピネフリン
- 抗ヒスタミン薬
- ステロイド
- ベータ作動薬
- その他
アナフィラキシー治療市場 –投与経路別
- 経口
- 非経口
- その他
アナフィラキシー治療市場 –アレルギーの種類別
- 食物アレルギー
- 薬
- 虫刺され
- その他
アナフィラキシー治療市場–流通チャネル別
- 病院薬局
- 小売販売
- その他
アナフィラキシー治療市場 –地理別
- 北アメリカ
- 米国
- カナダ
- メキシコ
< li>ヨーロッパ - フランス
- ドイツ
- イタリア
- イギリス
- スペイン
- 残りヨーロッパ
- アジア太平洋 (APAC)
- 中国
- インド
- 韓国
- 日本
- オーストラリア
- その他のアジア太平洋地域
- 中東およびアフリカ (MEA)
- 南アフリカ
- サウジアラビア
- アラブ首長国連邦
- 中東およびアフリカのその他の地域
- 南部および中央アメリカ (SCAM)
- ブラジル
- アルゼンチン
- その他の南中米
会社概要
- Amneal Pharmaceuticals Inc.
- Bioprojet
- Mylan NV
- >Adamis Pharmaceutical Corporation
- Abbott
- Pfizer Inc.
- Glaxosmithkline Plc.
- Merck And Co., Inc.
- テバ ファーマシューティカル インダストリーズ株式会社
- アルク・アベルó
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Anaphylaxis is an allergic reaction that can further lead to a fatal condition known as anaphylactic shock. Anaphylaxis occurs when the patient's body reacts to a foreign substance and produces a high amount of histamine that triggers an inflammatory response.
The growth of the anaphylaxis treatment market is attributed to the factors such as rising incidence of anaphylaxis, and recent approvals of epinephrine. Moreover, rise in cases of allergies post administration of covid-19 vaccines is also favoring the growth of the market
The anaphylaxis treatment market majorly consists of the players such as Amneal Pharmaceuticals Inc., Bioprojet, Mylan N.V., Adamis Pharmaceutical Corporation, Abbott, Pfizer Inc., Glaxosmithkline Plc., Merck And Co. Inc., Teva Pharmaceutical Industries Ltd., ALK-ABELLó among others.
The List of Companies - Anaphylaxis Treatment Market
- Amneal Pharmaceuticals Inc.
- Bioprojet
- Mylan N.V.
- Adamis Pharmaceutical Corporation
- Abbott
- Pfizer Inc.
- Glaxosmithkline Plc.,
- Merck And Co., Inc.
- Teva Pharmaceutical Industries Ltd.
- ALK-ABELLó
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Jun 2021
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2021
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jun 2021
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jun 2021
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2021
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2021
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Jun 2021
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Jun 2021
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)